Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
12/20/2007 | DE102006027791A1 AchE-NMDA-Kombinationswafer AchE NMDA combination wafer |
12/20/2007 | DE102006027790A1 Typ-2-Diabetes Kombinations-Wafer Type 2 diabetes combination wafer |
12/20/2007 | CA2635467A1 Bst2 inhibitor |
12/19/2007 | WO2007104145A1 Diagnostic compositions and treatment methods for conditions involving trophoblast cell death, differentiation, invasion and/or cell fusion and turnover |
12/19/2007 | EP1867718A2 Therapeutically useful synthetic oligonucleotides |
12/19/2007 | EP1867642A1 Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia |
12/19/2007 | EP1867641A1 Preventive or remedy for depression or anxiety neurosis |
12/19/2007 | EP1867639A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
12/19/2007 | EP1867348A2 Medical devices and applications of polyhydroxyalkanoate polymers |
12/19/2007 | EP1867343A2 Novel compounds |
12/19/2007 | EP1867342A1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |
12/19/2007 | EP1867341A1 Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease |
12/19/2007 | EP1867339A1 Anti-viral agent |
12/19/2007 | EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
12/19/2007 | EP1865770A2 The genetic risk assessment in heart failure: impact of the genetic variation of nos3 |
12/19/2007 | EP1682124B1 Pharmaceutical compositions based on idazoxan salt or one of its polymorphs |
12/19/2007 | EP1578366A4 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use |
12/19/2007 | EP1490045A4 In vivo use of glutathionone s-transferase activated nitric oxide donors |
12/19/2007 | EP1408949B1 Glycine betaine and its use as anti-hemorrhagic agent |
12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
12/19/2007 | EP1353694B1 Combinations of ezetimibe with aspirine for treating vascular conditions |
12/19/2007 | EP1284729A4 A(beta)42 lowering agents |
12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
12/19/2007 | EP1131449B1 Method for identifying inhibitors of ipc synthase |
12/19/2007 | EP1011678B1 Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders |
12/19/2007 | EP0912091B1 Use of gaba uptake inhibitors as anti-tussive agents |
12/19/2007 | CN101090734A Remedy for endometriosis |
12/19/2007 | CN101088563A Anticancer composition containing lomustine |
12/19/2007 | CN101088562A Anticancer composition containing ranimustine |
12/19/2007 | CN101088491A Anticancer composition |
12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
12/19/2007 | CN100355457C Dispersible pharmaceutical compositions |
12/19/2007 | CN100355423C Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor |
12/19/2007 | CN100355419C Therapeutic agent for overactive bladder |
12/19/2007 | CA2820023A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
12/19/2007 | CA2549115A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
12/18/2007 | US7310552 Apparatus for indirectly stimulating the vagus nerve with an electrical field |
12/18/2007 | US7309708 Serine protease inhibition via N-(distubstituted aminomethylcarbonyl)-2-[N-(1-sulfonylamido-1-cyclopropanyl)amido]pyrrolidines |
12/18/2007 | US7309704 Piperidinyl- and pyrimidinyl-ureas: N-(1-acetyl-4-piperidinyl)-N-methyl-N'-(5-(3,5-difluorophenyl)-2-pyrimidinyl)urea; metabolic disorders, eating disorders, disorders associated with obesity: type II diabetes, insulin resistance, hyperlipidemia or hypertension. |
12/18/2007 | US7309691 Combined pharmaceutical preparation containing LHRH-analogous substances and anti estrogens for treating gynaecological disorders |
12/18/2007 | US7309688 Topical application of formulation containing non-denatured, soy product in a carrier for inhibiting the progression of a cutaneous tumor |
12/18/2007 | US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
12/18/2007 | CA2436799C Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
12/18/2007 | CA2378436C Method for producing antibiotic composites |
12/18/2007 | CA2299471C Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
12/18/2007 | CA2103306C Extrudable compositions for topical or transdermal drug delivery |
12/15/2007 | CA2591350A1 Antacid and breath freshening composition |
12/13/2007 | WO2007143483A2 Combination of pazopanib and lapatinib for treating cancer |
12/13/2007 | WO2007143002A2 Nutraceutical treatments for diabetic and non-diabetic wound healing |
12/13/2007 | WO2007142369A1 Method for screening of anti-obesity agent |
12/13/2007 | WO2007142325A1 Preventive or remedy for inflammatory disease |
12/13/2007 | WO2007142309A1 Method of screening drug for treating kidney glomerulus |
12/13/2007 | WO2007142303A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
12/13/2007 | WO2007142297A1 Composition for prevention/treatment of hepatic disease |
12/13/2007 | WO2007142139A1 Method of identifying candidate for remedy of acute myeloid leukemia |
12/13/2007 | WO2007142118A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
12/13/2007 | WO2007141974A1 Nonhuman model animal of hypertension |
12/13/2007 | WO2007141667A2 Immunosuppressive extract of cordyceps sinensis and uses thereof |
12/13/2007 | WO2007140924A1 Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer |
12/13/2007 | WO2007140786A1 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
12/13/2007 | WO2007121546A8 Use of mas-g-protein-coupled receptor agonists in the treatment of the metabolic syndrome, its components and its complications |
12/13/2007 | WO2007110811A3 Use of the staudinger ligation in in vivo assembly of a biologically active compound |
12/13/2007 | WO2007093635A3 Proteasom or ups inhibitor for treating infections with influenza viruses |
12/13/2007 | WO2006097358A3 Analgesic combination of sodium channel blockers with opioid antagonists |
12/13/2007 | WO2005115417A3 Polycationic antimicrobial therapeutic |
12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |
12/13/2007 | US20070287718 Methods for the Treatment of Multiple Myeloma Using Roscovitine |
12/13/2007 | US20070287714 Warming and Nonirritating Lubricant Compositions and Method of Comparing Irritation |
12/13/2007 | US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
12/13/2007 | US20070287702 Thioridazine And Derivatives Thereof For Reversing Anti-Microbial Drug-Resistance |
12/13/2007 | US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof |
12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
12/13/2007 | US20070286889 Weight management system for obese animals |
12/13/2007 | US20070286867 Combination Therapy |
12/13/2007 | US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard) |
12/13/2007 | US20070286843 Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof |
12/13/2007 | US20070286805 Methods of Validating Target for Modulating Insulin Action, Screening for Modulators of Insulin Action and Therapeutic Uses Thereof |
12/13/2007 | CA2654623A1 An anti-nr10/il-31ra antibody for use in preventing or treating an inflammatory disease |
12/13/2007 | CA2654026A1 Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
12/13/2007 | CA2653787A1 Composition for preventing the occurrence of cardiovascular event in multiple risk patient |
12/13/2007 | CA2653237A1 Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer |
12/13/2007 | CA2636288A1 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
12/12/2007 | EP1865061A2 IL-17 homologous polypeptides and therapeutic uses thereof |
12/12/2007 | EP1864997A1 ROR ALPHA PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
12/12/2007 | EP1864680A2 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
12/12/2007 | EP1863905A2 Method for activating natural killer cells by tumour cell preparations in vitro |
12/12/2007 | EP1863573A1 Treatment of laminitis |
12/12/2007 | EP1863534A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
12/12/2007 | EP1863533A1 Combination of interleukin-6 antagonists and antiproliferative drugs |
12/12/2007 | EP1863510A1 Methods for treating parkinson's disease |
12/12/2007 | EP1863493A1 Corticosteroid containing formulation for treating psoriasis, eczema, ulcer and burns. |
12/12/2007 | EP1863450A1 Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations |
12/12/2007 | EP1863445A1 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
12/12/2007 | EP1670489B1 Use of xenon with hypothermia for treating neonatal asphyxia |
12/12/2007 | EP1532250B1 Fcyriia transgenic animal model for autoimmune disease |
12/12/2007 | EP1505976B1 Synergistic combination of an opioid analgesic and a nsaid |
12/12/2007 | EP1496933A4 Use of interleukin-19 to treat ovarian cancer |
12/12/2007 | EP1496880A4 SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-kB INHIBITORS AND ANTI-NEOPLASTIC AGENTS |